Have you considered repurposing your existing approved drug for a rare disease indication? This strategy is significantly cheaper and far less time-consuming that traditional drug development, and it produces a viable treatment option for patients in a new indication. For a comprehensive take on why repurposing is a strong development strategy, approaches for it, and challenges to be considered, check out this white paper.
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
